Raymond James Financial Inc Veracyte, Inc. Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Veracyte, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 41,064 shares of VCYT stock, worth $1.86 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,064Holding current value
$1.86 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VCYT
# of Institutions
320Shares Held
80.8MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$352 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$350 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$227 Million0.27% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$191 Million0.03% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$190 Million1.46% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $3.24B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...